Ph.D., Senior Director, Scientific Affairs, Sampled
Biography
My mission at Sampled is to provide expert technical resources to clients, evaluate and adopt new technologies and to coordinate outreach initiatives designed to promote understanding of the services provided by Sampled to commercial and academic clients around the world. In my time at Sampled, I previously directed our Sample Processing Services laboratories, with oversight of all operations relating to blood fractionation, cell and stem cell culture and nucleic acid extraction. These laboratories have evolved to establish a new paradigm in SMART laboratory operations. I also helped to build the third largest SARS-CoV2 testing lab in the United States. I currently serve as the Director of the Sampled College of American Pathologists (CAP) Biorepository.
In my previous career I served on the faculties of Rutgers University and the Baylor College of Medicine with background training as a bench scientist in Genetics and Neurodevelopment.
Talk
Clinical & Research Tools Showcase:
Sampled
Sampled SMART Labs mission is to be the lab behind every transformative health innovation. Our vision is a world where we make it faster and easier for health innovators to improve human health by providing comprehensive sample collection and processing solutions.
The Leading Global Integrated Analytical Biorepository
Sampled SMART lab services allow our clients to focus on the objectives of their research.
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S2 - January 25 2.45 P.M.-4.00 P.M.,Showcase Track S2 - January 26 1.30 P.M.-4.00 P.M.,Showcase Track S2 - January 27 1.15 P.M.-1.30 P.M.
The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
